Varex Imaging (VREX) Stock Overview
Designs, manufactures, and sells X-ray imaging components. More details
| Snowflake Score | |
|---|---|
| Valuation | 6/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
VREX Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Varex Imaging Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$11.61 |
| 52 Week High | US$14.57 |
| 52 Week Low | US$6.76 |
| Beta | 1.0 |
| 1 Month Change | 10.57% |
| 3 Month Change | -18.01% |
| 1 Year Change | 33.30% |
| 3 Year Change | -47.25% |
| 5 Year Change | -52.65% |
| Change since IPO | -57.43% |
Recent News & Updates
VREX: Future Upside Will Depend On Q2 2026 Revenue And Margin Delivery
Analysts recently raised their price target on Varex Imaging by $2. This change reflects updated views on revenue growth, profit margin potential, and a lower assumed future P/E multiple, while keeping fair value estimates unchanged.
VREX: Refined Discount Rate And P/E Assumptions Will Support Future Repricing
Analysts recently raised their price target on Varex Imaging by $2, reflecting updated assumptions on discount rate, profit margin, and future P/E. They see these assumptions as better aligned with the company’s risk and earnings profile.VREX: Higher Profitability Assumptions Will Support A Repriced Earnings Multiple
Analysts have raised their average price target for Varex Imaging by $1, reflecting updated views on fair value, profitability assumptions, and P/E expectations cited in recent research, including the latest move from B. Riley.VREX: Future Returns Will Hinge On Executing Q2 2026 Revenue Guidance
Narrative Update on Varex Imaging Analysts have lifted their price target on Varex Imaging by $2, citing updated assumptions for discount rates, revenue growth, profit margins, and future P/E that support a refreshed view of the company’s valuation profile. Analyst Commentary Even with the updated price target, some bearish analysts remain cautious.VREX: Future Returns Will Depend On Delivering Q2 2026 Guidance Execution
Analysts have lifted their price target on Varex Imaging to $16.0 from $14.5, citing updated assumptions around fair value, discount rate, revenue, profit margin and future P/E following recent research that included a $2 increase in target price at B. Riley.Recent updates
VREX: Future Upside Will Depend On Q2 2026 Revenue And Margin Delivery
Analysts recently raised their price target on Varex Imaging by $2. This change reflects updated views on revenue growth, profit margin potential, and a lower assumed future P/E multiple, while keeping fair value estimates unchanged.VREX: Refined Discount Rate And P/E Assumptions Will Support Future Repricing
Analysts recently raised their price target on Varex Imaging by $2, reflecting updated assumptions on discount rate, profit margin, and future P/E. They see these assumptions as better aligned with the company’s risk and earnings profile.VREX: Higher Profitability Assumptions Will Support A Repriced Earnings Multiple
Analysts have raised their average price target for Varex Imaging by $1, reflecting updated views on fair value, profitability assumptions, and P/E expectations cited in recent research, including the latest move from B. Riley.VREX: Future Returns Will Hinge On Executing Q2 2026 Revenue Guidance
Narrative Update on Varex Imaging Analysts have lifted their price target on Varex Imaging by $2, citing updated assumptions for discount rates, revenue growth, profit margins, and future P/E that support a refreshed view of the company’s valuation profile. Analyst Commentary Even with the updated price target, some bearish analysts remain cautious.VREX: Future Returns Will Depend On Delivering Q2 2026 Guidance Execution
Analysts have lifted their price target on Varex Imaging to $16.0 from $14.5, citing updated assumptions around fair value, discount rate, revenue, profit margin and future P/E following recent research that included a $2 increase in target price at B. Riley.VREX: Future Returns Will Balance Q4 Beat Against Ongoing Execution Risks
Analysts have revised their fair value estimate for Varex Imaging to $14.50 from $12.00, citing updated assumptions on the discount rate, revenue growth, profit margins and future P/E. This follows recent research that included a lower Street price target of $18 from $23, after Q4 revenue of $229M came in above prior estimates and guidance.It Looks Like Varex Imaging Corporation's (NASDAQ:VREX) CEO May Expect Their Salary To Be Put Under The Microscope
Feb 05
VREX: Future Returns Will Reflect Cautious Stance After Lowered Price Outlook
Narrative Update Analysts have trimmed their price target on Varex Imaging by $5 to $18, citing recent Q4 revenue of $229M coming in above their estimates and within guidance, along with Q1 2026 revenue guidance of $200M to $215M that aligns closely with current expectations. Analyst Commentary Bearish analysts are reacting to the recent update by trimming their expectations, even as the latest numbers line up with prior guidance and estimates.VREX: Future Returns Will Reflect Trimmed Outlook After Q1 2026 Revenue Guidance
Narrative Update on Varex Imaging The analyst consensus price target for Varex Imaging has shifted to US$18 from US$23, with analysts pointing to the recent Q4 revenue outcome of US$229m versus prior expectations and the Q1 2026 guidance range of US$200m to US$215m as key inputs behind the revision. Analyst Commentary Bearish analysts have responded to the latest results and guidance by trimming their expectations, even though the recent Q4 revenue outcome of US$229m sat at the high end of management's US$210m to US$230m range and ahead of prior estimates.Is Varex Imaging (NASDAQ:VREX) A Risky Investment?
Jan 09VREX: Future Performance Will Reflect Trimmed Outlook Amid Solid Recent Results
Analysts have trimmed their price target on Varex Imaging to $18 from $23, citing slightly softer long term growth assumptions, despite recent quarterly revenues and forward guidance coming in ahead of or in line with prior expectations. Analyst Commentary Bearish analysts acknowledge Varex Imaging's better than expected quarterly performance and solid positioning within its end markets, but remain cautious on the durability of growth and the balance of risk and reward at current levels.Varex Imaging Corporation (NASDAQ:VREX) Shares Could Be 35% Below Their Intrinsic Value Estimate
Nov 20Varex Imaging Corporation (NASDAQ:VREX) Just Reported Earnings, And Analysts Cut Their Target Price
Aug 10The Returns At Varex Imaging (NASDAQ:VREX) Aren't Growing
Aug 06Calculating The Intrinsic Value Of Varex Imaging Corporation (NASDAQ:VREX)
Jul 19These 4 Measures Indicate That Varex Imaging (NASDAQ:VREX) Is Using Debt Extensively
Jun 10Earnings Beat: Varex Imaging Corporation Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
May 11Lacklustre Performance Is Driving Varex Imaging Corporation's (NASDAQ:VREX) 32% Price Drop
Apr 25Little Excitement Around Varex Imaging Corporation's (NASDAQ:VREX) Revenues As Shares Take 32% Pounding
Apr 25Be Wary Of Varex Imaging (NASDAQ:VREX) And Its Returns On Capital
Apr 04Varex Imaging Corporation: A Mixed Picture
Jan 21Varex Imaging (NASDAQ:VREX) Is Finding It Tricky To Allocate Its Capital
Dec 19There's Reason For Concern Over Varex Imaging Corporation's (NASDAQ:VREX) Massive 29% Price Jump
Nov 07Does Varex Imaging (NASDAQ:VREX) Have A Healthy Balance Sheet?
Oct 22
Expanding In India And Innovating In Photon Technology Boosts Prospects Despite Challenges In China And Semiconductor Softness
Expansion into India and focus on photon counting technology aim to recover market share in radiographic and dental sectors, potentially increasing revenue.Varex Imaging: Headroom Capped Without Higher Earnings On Capital Employed
Sep 11Little Excitement Around Varex Imaging Corporation's (NASDAQ:VREX) Earnings
Aug 20We Like Varex Imaging's (NASDAQ:VREX) Earnings For More Than Just Statutory Profit
May 10Varex Imaging Corporation: The Picture Is Cloudy After Quarterly Results
Feb 07We Like These Underlying Return On Capital Trends At Varex Imaging (NASDAQ:VREX)
Dec 14Is Varex Imaging (NASDAQ:VREX) A Risky Investment?
Nov 05Shareholder Returns
| VREX | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | -7.3% | -4.1% | 0.9% |
| 1Y | 33.3% | -18.2% | 28.2% |
Return vs Industry: VREX exceeded the US Medical Equipment industry which returned -18.5% over the past year.
Return vs Market: VREX exceeded the US Market which returned 27.8% over the past year.
Price Volatility
| VREX volatility | |
|---|---|
| VREX Average Weekly Movement | 5.7% |
| Medical Equipment Industry Average Movement | 8.2% |
| Market Average Movement | 7.1% |
| 10% most volatile stocks in US Market | 16.2% |
| 10% least volatile stocks in US Market | 3.2% |
Stable Share Price: VREX has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: VREX's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2016 | 2,400 | Sunny Sanyal | www.vareximaging.com |
Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. It operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers.
Varex Imaging Corporation Fundamentals Summary
| VREX fundamental statistics | |
|---|---|
| Market cap | US$486.68m |
| Earnings (TTM) | -US$67.70m |
| Revenue (TTM) | US$854.40m |
0.6x
P/S Ratio-7.2x
P/E RatioIs VREX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| VREX income statement (TTM) | |
|---|---|
| Revenue | US$854.40m |
| Cost of Revenue | US$562.60m |
| Gross Profit | US$291.80m |
| Other Expenses | US$359.50m |
| Earnings | -US$67.70m |
Last Reported Earnings
Jan 02, 2026
Next Earnings Date
May 07, 2026
| Earnings per share (EPS) | -1.62 |
| Gross Margin | 34.15% |
| Net Profit Margin | -7.92% |
| Debt/Equity Ratio | 74.9% |
How did VREX perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/05/03 07:11 |
| End of Day Share Price | 2026/05/01 00:00 |
| Earnings | 2026/01/02 |
| Annual Earnings | 2025/10/03 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Varex Imaging Corporation is covered by 9 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Anderson Schock | B. Riley Securities, Inc. |
| Lawrence Solow | CJS Securities, Inc. |
| Rajbir Denhoy | Jefferies LLC |